Wird geladen...
ENDPOINTS AND CLINICAL TRIAL DESIGN FOR NONALCOHOLIC STEATOHEPATITIS
Nonalcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease in the general population. Nonalcoholic steatohepatitis (NASH), the aggressive form of NAFLD, is associated with an increased risk of liver-related mortality and cardiovascular disease. Currently, a liver biopsy is t...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2011
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014460/ https://ncbi.nlm.nih.gov/pubmed/21520200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.24376 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|